Global phase III study of gemcitabine plus paclitaxel (GT) vs. paclitaxel (T) as frontline therapy for metastatic breast cancer (MBC) : first report of overall survival

• ALBAIN KS

収録刊行物

• J Clin Oncol

  J Clin Oncol 2004

詳細情報

• CRID: 1572824500432400000
• NII論文ID: 10021288338
• データソース種別:
  • CiNii Articles